The University of Queensland

Clinical practice guidelines for the management of melanoma in Australia and New Zealand

Aitken, Joanne F., Barbour, Andrew, Burmeister, Bryan, Taylor, Simon, Walpole, Euan, Australian Cancer Network, Smithers, Bernhard M. and Melanoma Guidelines Revision Working Party (2008). Clinical practice guidelines for the management of melanoma in Australia and New Zealand. Sydney, Australia: Cancer Council Australia; Australian Cancer Network; Ministry of Health, New Zealand.

Thoracoscopic and laparoscopic esophagectomy

Smithers, B. Mark, Thomson, Iain and Barbour, Andrew (2018). Thoracoscopic and laparoscopic esophagectomy. Operative thoracic surgery. (pp. 377-386) edited by Larry R. Kaiser, Sarah K. Thompson and Glyn G. Jamieson. Boca Raton, FL, United States: CRC Press. doi: 10.1201/9781315113777

ctDNA: a promising biomarker for predicting recurrence in BRAF-negative melanoma patients

Aoude, Lauren G., Brosda, Sandra, Ng, Jessica, Lonie, James M., Belle, Clemence J., Patel, Kalpana, Koufariotis, Lambros T., Wood, Scott, Atkinson, Victoria, Smithers, B. Mark, Pearson, John V., Waddell, Nicola, Barbour, Andrew P. and Bonazzi, Vanessa F. (2023). ctDNA: a promising biomarker for predicting recurrence in BRAF-negative melanoma patients. Journal of Molecular Diagnostics, 25 (10), 771-781. doi: 10.1016/j.jmoldx.2023.06.014

C‐reactive protein is a prognostic biomarker in pancreatic ductal adenocarcinoma patients

Bonazzi, Vanessa F., Aoude, Lauren G., Brosda, Sandra, Bradford, Julia J., Lonie, James M., Loffler, Kelly A., Gartside, Michael G., Patel, Kalpana, Mukhopadhyay, Pamela, Keane, Colm, Gebski, Val, Kench, James G., Goldstein, David, Waddell, Nicola, Barbour, Andrew P. and the Australasian Gastro‐Intestinal Trials Group (AGITG) GAP investigators (2023). C‐reactive protein is a prognostic biomarker in pancreatic ductal adenocarcinoma patients. Asia-Pacific Journal of Clinical Oncology. doi: 10.1111/ajco.13993

Multi-omic features of oesophageal adenocarcinoma in patients treated with preoperative neoadjuvant therapy

M. Naeini, Marjan, Newell, Felicity, Aoude, Lauren G., Bonazzi, Vanessa F., Patel, Kalpana, Lampe, Guy, Koufariotis, Lambros T., Lakis, Vanessa, Addala, Venkateswar, Kondrashova, Olga, Johnston, Rebecca L., Sharma, Sowmya, Brosda, Sandra, Holmes, Oliver, Leonard, Conrad, Wood, Scott, Xu, Qinying, Thomas, Janine, Walpole, Euan, Tao Mai, G., Ackland, Stephen P., Martin, Jarad, Burge, Matthew, Finch, Robert, Karapetis, Christos S., Shannon, Jenny, Nott, Louise, Bohmer, Robert, Wilson, Kate ... Waddell, Nicola (2023). Multi-omic features of oesophageal adenocarcinoma in patients treated with preoperative neoadjuvant therapy. Nature Communications, 14 (1) 3155, 3155. doi: 10.1038/s41467-023-38891-x

Introducing robotic oesophagectomy into an Australian practice: an assessment of the early procedural outcomes and learning curve

Narendra, Aaditya and Barbour, Andrew (2023). Introducing robotic oesophagectomy into an Australian practice: an assessment of the early procedural outcomes and learning curve. ANZ Journal of Surgery, 93 (5), 1300-1305. doi: 10.1111/ans.18445

Textbook outcomes for oesophagectomy: A valid composite measure assessment tool for surgical performance in a specialist unit

Wu, Michael Yulong, McGregor, Richard J., Scott, Justin, Smithers, B. Mark, Thomas, Janine, Frankel, Adam, Barbour, Andrew and Thomson, Iain (2023). Textbook outcomes for oesophagectomy: A valid composite measure assessment tool for surgical performance in a specialist unit. European Journal of Surgical Oncology, 49 (9) 106897, 106897. doi: 10.1016/j.ejso.2023.03.233

Heritable defects in telomere and mitotic function selectively predispose to sarcomas

Ballinger, Mandy L., Pattnaik, Swetansu, Mundra, Piyushkumar A., Zaheed, Milita, Rath, Emma, Priestley, Peter, Baber, Jonathan, Ray-Coquard, Isabelle, Isambert, Nicholas, Causeret, Sylvain, van der Graaf, Winette T.A., Puri, Ajay, Duffaud, Florence, Le Cesne, Axel, Seddon, Beatrice, Chandrasekar, Coonoor, Schiffman, Joshua D., Brohl, Andrew S., James, Paul A., Kurtz, Jean-Emmanuel, Penel, Nicolas, Myklebost, Ola, Meza-Zepeda, Leonardo A., Pickett, Hilda, Kansara, Maya, Waddell, Nicola, Kondrashova, Olga, Pearson, John V., Barbour, Andrew P. ... Thomas, David M. (2023). Heritable defects in telomere and mitotic function selectively predispose to sarcomas. Science, 379 (6629), 253-260. doi: 10.1126/science.abj4784

Author Correction: A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns (Nature Communications, (2020), 11, 1, (728), 10.1038/s41467-019-13825-8)

Jiao, Wei, Atwal, Gurnit, Polak, Paz, Karlic, Rosa, Cuppen, Edwin, Al-Shahrour, Fatima, Atwal, Gurnit, Bailey, Peter J., Biankin, Andrew V., Boutros, Paul C., Campbell, Peter J., Chang, David K., Cooke, Susanna L., Deshpande, Vikram, Faltas, Bishoy M., Faquin, William C., Garraway, Levi, Getz, Gad, Grimmond, Sean M., Haider, Syed, Hoadley, Katherine A., Jiao, Wei, Kaiser, Vera B., Karlic, Rosa, Kato, Mamoru, Kübler, Kirsten, Lazar, Alexander J., Li, Constance H., Louis, David N. ... von Mering, Christian (2022). Author Correction: A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns (Nature Communications, (2020), 11, 1, (728), 10.1038/s41467-019-13825-8). Nature Communications, 13 (1) 7573. doi: 10.1038/s41467-022-32329-6

Author Correction: Combined burden and functional impact tests for cancer driver discovery using DriverPower (Nature Communications, (2020), 11, 1, (734), 10.1038/s41467-019-13929-1)

Shuai, Shimin, Abascal, Federico, Amin, Samirkumar B., Bader, Gary D., Bandopadhayay, Pratiti, Barenboim, Jonathan, Beroukhim, Rameen, Bertl, Johanna, Boroevich, Keith A., Brunak, Søren, Campbell, Peter J., Carlevaro-Fita, Joana, Chakravarty, Dimple, Chan, Calvin Wing Yiu, Chen, Ken, Choi, Jung Kyoon, Deu-Pons, Jordi, Dhingra, Priyanka, Diamanti, Klev, Feuerbach, Lars, Fink, J. Lynn, Fonseca, Nuno A., Frigola, Joan, Gambacorti-Passerini, Carlo, Garsed, Dale W., Gerstein, Mark, Getz, Gad, Guo, Qianyun, Gut, Ivo G. ... von Mering, Christian (2022). Author Correction: Combined burden and functional impact tests for cancer driver discovery using DriverPower (Nature Communications, (2020), 11, 1, (734), 10.1038/s41467-019-13929-1). Nature Communications, 13 (1) 7571. doi: 10.1038/s41467-022-32343-8

Author Correction: Integrative pathway enrichment analysis of multivariate omics data (Nature Communications, (2020), 11, 1, (735), 10.1038/s41467-019-13983-9)

Paczkowska, Marta, Barenboim, Jonathan, Sintupisut, Nardnisa, Fox, Natalie S., Zhu, Helen, Abd-Rabbo, Diala, Mee, Miles W., Boutros, Paul C., Abascal, Federico, Amin, Samirkumar B., Bader, Gary D., Beroukhim, Rameen, Bertl, Johanna, Boroevich, Keith A., Brunak, Søren, Campbell, Peter J., Carlevaro-Fita, Joana, Chakravarty, Dimple, Chan, Calvin Wing Yiu, Chen, Ken, Choi, Jung Kyoon, Deu-Pons, Jordi, Dhingra, Priyanka, Diamanti, Klev, Feuerbach, Lars, Fink, J. Lynn, Fonseca, Nuno A., Frigola, Joan, Gambacorti-Passerini, Carlo ... von Mering, Christian (2022). Author Correction: Integrative pathway enrichment analysis of multivariate omics data (Nature Communications, (2020), 11, 1, (735), 10.1038/s41467-019-13983-9). Nature Communications, 13 (1) 7570. doi: 10.1038/s41467-022-32342-9

Laparoscopic fundoplication versus laparoscopic Roux-en-Y gastric bypass for gastro-oesophageal reflux disease in obese patients: protocol for a randomized clinical trial

Frankel, Adam, Thomson, Iain, Shah, Ayesha, Chen, Chen, Zahir, Syeda Farah, Barbour, Andrew, Holtmann, Gerald and Mark Smithers, B (2022). Laparoscopic fundoplication versus laparoscopic Roux-en-Y gastric bypass for gastro-oesophageal reflux disease in obese patients: protocol for a randomized clinical trial. BJS Open, 6 (6) zrac132. doi: 10.1093/bjsopen/zrac132

Comparative genomics provides etiological and biological insights into melanoma subtypes

Newell, Felicity, Johansson, Peter A., Wilmott, James S., Nones, Katia, Lakis, Vanessa, Pritchard, Antonia L., Lo, Serigne N., Rawson, Robert V., Kazakoff, Stephen H., Colebatch, Andrew J., Koufariotis, Lambros T., Ferguson, Peter M., Wood, Scott, Leonard, Conrad, Law, Matthew H., Brooks, Kelly M., Broit, Natasa, Palmer, Jane M., Couts, Kasey L., Vergara, Ismael A., Long, Georgina V., Barbour, Andrew P., Nieweg, Omgo E., Shivalingam, Brindha, Robinson, William A., Stretch, Jonathan R., Spillane, Andrew J., Saw, Robyn P.M., Shannon, Kerwin F. ... Hayward, Nicholas K. (2022). Comparative genomics provides etiological and biological insights into melanoma subtypes. Cancer Discovery, 12 (12), OF1-OF24. doi: 10.1158/2159-8290.cd-22-0603

Comparison of actionable events detected in cancer genomes by whole-genome sequencing, in silico whole-exome and mutation panels

Ramarao-Milne, P, Kondrashova, O, Patch, A-M, Nones, K, Koufariotis, L T, Newell, F, Addala, V, Lakis, V, Holmes, O, Leonard, C, Wood, S, Xu, Q, Mukhopadhyay, P, Naeini, M M, Steinfort, D, Williamson, J P, Bint, M, Pahoff, C, Nguyen, P T, Twaddell, S, Arnold, D, Grainge, C, Basirzadeh, F, Fielding, D, Dalley, A J, Chittoory, H, Simpson, P T, Aoude, L G, Bonazzi, V F ... Waddell, N (2022). Comparison of actionable events detected in cancer genomes by whole-genome sequencing, in silico whole-exome and mutation panels. ESMO Open, 7 (4) 100540, 1-11. doi: 10.1016/j.esmoop.2022.100540

Neoadjuvant chemoradiotherapy and surgery for esophageal squamous cell carcinoma versus definitive chemoradiotherapy with salvage surgery as needed: The study protocol for the randomized controlled NEEDS trial

Nilsson, Magnus, Olafsdottir, Halla, Alexandersson von Döbeln, Gabriella, Villegas, Fernanda, Gagliardi, Giovanna, Hellström, Mats, Wang, Qiao-Li, Johansson, Hemming, Gebski, Val, Hedberg, Jakob, Klevebro, Fredrik, Markar, Sheraz, Smyth, Elizabeth, Lagergren, Pernilla, Al-Haidari, Ghazwan, Rekstad, Lars Cato, Aahlin, Eirik Kjus, Wallner, Bengt, Edholm, David, Johansson, Jan, Szabo, Eva, Reynolds, John V., Pramesh, C. S., Mummudi, Naveen, Joshi, Amit, Ferri, Lorenzo, Wong, Rebecca KS, O’Callaghan, Chris, Lukovic, Jelena ... Lordick, Florian (2022). Neoadjuvant chemoradiotherapy and surgery for esophageal squamous cell carcinoma versus definitive chemoradiotherapy with salvage surgery as needed: The study protocol for the randomized controlled NEEDS trial. Frontiers in Oncology, 12 917961. doi: 10.3389/fonc.2022.917961

Elevation of fatty acid desaturase 2 in esophageal adenocarcinoma increases polyunsaturated lipids and may exacerbate bile acid‐induced DNA damage

Molendijk, Jeffrey, Kolka, Cathryn M., Cairns, Henry, Brosda, Sandra, Mohamed, Ahmed, Shah, Alok K., Brown, Ian, Hodson, Mark P., Hennessy, Thomas, Liu, Guanghao, Stoll, Thomas, Richards, Renee S., Gartside, Michael, Patel, Kalpana, Clemons, Nicholas J., Phillips, Wayne A., Barbour, Andrew, Westerhuis, Johan A. and Hill, Michelle M. (2022). Elevation of fatty acid desaturase 2 in esophageal adenocarcinoma increases polyunsaturated lipids and may exacerbate bile acid‐induced DNA damage. Clinical and Translational Medicine, 12 (5) e810, 1-19. doi: 10.1002/ctm2.810

ctDNA as a biomarker of progression in oesophageal adenocarcinoma

Bonazzi, V. F., Aoude, L. G., Brosda, S., Lonie, J. M., Patel, K., Bradford, J. J., Koufariotis, L. T., Wood, S., Smithers, B. Mark, Waddell, N. and Barbour, A. P. (2022). ctDNA as a biomarker of progression in oesophageal adenocarcinoma. ESMO Open, 7 (3) 100452, 100452. doi: 10.1016/j.esmoop.2022.100452

Patient-reported outcome (PRO) results from the AGITG DOCTOR trial: a randomised phase 2 trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinoma

Mercieca-Bebber, R., Barnes, E. H., Wilson, K., Samoon, Z., Walpole, E., Mai, T., Ackland, S., Burge, M., Dickie, G., Watson, D., Leung, J., Wang, T., Bohmer, R., Cameron, D., Simes, J., Gebski, V., Smithers, M., Thomas, J., Zalcberg, J. and Barbour, A. P. (2022). Patient-reported outcome (PRO) results from the AGITG DOCTOR trial: a randomised phase 2 trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinoma. BMC Cancer, 22 (1) 276, 1-11. doi: 10.1186/s12885-022-09270-4

C5b-9 membrane attack complex formation and extracellular vesicle shedding in Barrett’s esophagus and esophageal adenocarcinoma

Kolka, Cathryn M., Webster, Julie, Lepletier, Ailin, Winterford, Clay, Brown, Ian, Richards, Renee S., Zelek, Wioleta M., Cao, Yilang, Khamis, Ramlah, Shanmugasundaram, Karthik B., Wuethrich, Alain, Trau, Matt, Brosda, Sandra, Barbour, Andrew, Shah, Alok K., Eslick, Guy D., Clemons, Nicholas J., Morgan, B. Paul and Hill, Michelle M. (2022). C5b-9 membrane attack complex formation and extracellular vesicle shedding in Barrett’s esophagus and esophageal adenocarcinoma. Frontiers in Immunology, 13 842023, 842023. doi: 10.3389/fimmu.2022.842023

Outcomes after totally minimally invasive versus hybrid and open Ivor Lewis oesophagectomy: results from the International Esodata Study Group

van der Wilk, Berend J., Hagens, Eliza R. C., Eyck, Ben M., Gisbertz, Suzanne S., van Hillegersberg, Richard, Nafteux, Philippe, Schröder, Wolfgang, Nilsson, Magnus, Wijnhoven, Bas P. L., Lagarde, Sjoerd M., van Berge Henegouwen, Mark I., International Esodata Study Group Collaborators , Smithers, Mark, Thomson, Iain, Barbour, Andrew and Thomas, Janine (2022). Outcomes after totally minimally invasive versus hybrid and open Ivor Lewis oesophagectomy: results from the International Esodata Study Group. British Journal of Surgery, 109 (3), 283-290. doi: 10.1093/bjs/znab432

Genomic and molecular analyses identify molecular subtypes of pancreatic cancer recurrence

Dreyer, Stephan B., Upstill-Goddard, Rosie, Legrini, Assya, Biankin, Andrew V., Allison, Sarah, Beraldi, Dario, Cameron, Euan, Chang, David K., Cooke, Susanna L., Cunningham, Richard, Dreyer, Stephan, Grimwood, Paul, Kelly, Shane, Marshall, John, McDade, Brian, Musgrove, Elizabeth A., Ramsay, Donna, Evers, Lisa, Rebus, Selma, Rahib, Lola, Serrels, Bryan, Jamieson, Nigel B., McKay, Colin J., Westwood, Paul, Williams, Nicola, Duthie, Fraser, Shen, William, Pea, Antonio, Johns, Amber L. ... Bassi, Claudio (2022). Genomic and molecular analyses identify molecular subtypes of pancreatic cancer recurrence. Gastroenterology, 162 (1), 320-324. doi: 10.1053/j.gastro.2021.09.022

AGITG MASTERPLAN: a randomised phase II study of modified FOLFIRINOX alone or in combination with stereotactic body radiotherapy for patients with high-risk and locally advanced pancreatic cancer

Oar, Andrew, Lee, Mark, Le, Hien, Wilson, Kate, Aiken, Chris, Chantrill, Lorraine, Simes, John, Nguyen, Nam, Barbour, Andrew, Samra, Jaswinder, Sjoquist, Katrin M., Moore, Alisha, Espinoza, David, Gebski, Val, Yip, Sonia, Chu, Julie, Kneebone, Andrew and Goldstein, David (2021). AGITG MASTERPLAN: a randomised phase II study of modified FOLFIRINOX alone or in combination with stereotactic body radiotherapy for patients with high-risk and locally advanced pancreatic cancer. BMC Cancer, 21 (1) 936. doi: 10.1186/s12885-021-08666-y

DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical association

Lakis, Vanessa, Lawlor, Rita T., Newell, Felicity, Patch, Ann-Marie, Mafficini, Andrea, Sadanandam, Anguraj, Koufariotis, Lambros T., Johnston, Rebecca L., Leonard, Conrad, Wood, Scott, Rusev, Borislav, Corbo, Vincenzo, Luchini, Claudio, Cingarlini, Sara, Landoni, Luca, Salvia, Roberto, Milella, Michele, Chang, David, Bailey, Peter, Jamieson, Nigel B., Duthie, Fraser, Gingras, Marie-Claude, Muzny, Donna M., Wheeler, David A., Gibbs, Richard A., Milione, Massimo, Chantrill, Lorraine A., Timpson, Paul, Chou, Angela ... Scarpa, Aldo (2021). DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical association. Communications Biology, 4 (1) 155, 1-11. doi: 10.1038/s42003-020-01469-0

ROR1 and ROR2 expression in pancreatic cancer

Liu, Dongli, Sharbeen, George, Phillips, Phoebe, Johns, Amber L., Gill, Anthony J., Chantrill, Lorraine A., Timpson, Paul, Chou, Angela, Pajic, Marina, Dwarte, Tanya, Herrmann, David, Vennin, Claire, Cox, Thomas R., Pereira, Brooke, Ritchie, Shona, Reed, Daniel A., Chambers, Cecilia R., Metcalf, Xanthe, Nobis, Max, Waddell, Nicola, Pearson, John V., Patch, Ann-Marie, Nones, Katia, Newell, Felicity, Mukhopadhyay, Pamela, Addala, Venkateswar, Kazakoff, Stephen, Holmes, Oliver, Leonard, Conrad ... Ford, Caroline E. (2021). ROR1 and ROR2 expression in pancreatic cancer. BMC Cancer, 21 (1) 1199. doi: 10.1186/s12885-021-08952-9

Responsiveness and convergent validity of QLU-C10D and EQ-5D-3L in assessing short-term quality of life following esophagectomy

Bulamu, Norma B., Vissapragada, Ravi, Chen, Gang, Ratcliffe, Julie, Mudge, Louise A., Smithers, B. Mark, Isenring, Elizabeth A., Smith, Lorelle, Jamieson, Glyn G., Watson, David I., Bessell, Justin, Barbour, Andrew, Aly, Ahmad, Archer, Stephen, Ballal, Mohammed, Barbon, Jessica, Benton, Katie, Bond, Melissa, Berryman, Melissa, Bright, Tim, Cade, Richard, Cardamis, Anna, Carroll, Rosemary, Cashman, Kara, Chan, Larissa, Chapman, Brooke, Chapman, Sally, Chen, Derek, Chisholm, Jacob ... on behalf of The Australian Immunonutrition Study Group (2021). Responsiveness and convergent validity of QLU-C10D and EQ-5D-3L in assessing short-term quality of life following esophagectomy. Health and Quality of Life Outcomes, 19 (1) 233, 1-11. doi: 10.1186/s12955-021-01867-w

Characterizing the heterogeneity of small extracellular vesicle populations in multiple cancer types via an ultrasensitive chip

Wang, Jing, Wuethrich, Alain, Lobb, Richard J., Antaw, Fiach, Sina, Abu Ali Ibn, Lane, Rebecca E., Zhou, Quan, Zieschank, Chloe, Bell, Caroline, Bonazzi, Vanessa F., Aoude, Lauren G., Everitt, Sarah, Yeo, Belinda, Barbour, Andrew P., Möller, Andreas and Trau, Matt (2021). Characterizing the heterogeneity of small extracellular vesicle populations in multiple cancer types via an ultrasensitive chip. ACS Sensors, 6 (9) acssensors.1c00358, 3182-3194. doi: 10.1021/acssensors.1c00358

Understanding the immuno-biology of oesophageal adenocarcinoma: towards improved therapeutic approaches

Lonie, James M., Barbour, Andrew P. and Dolcetti, Riccardo (2021). Understanding the immuno-biology of oesophageal adenocarcinoma: towards improved therapeutic approaches. Cancer Treatment Reviews, 98 102219, 1-13. doi: 10.1016/j.ctrv.2021.102219

Radiomics biomarkers correlate with CD8 expression and predict immune signatures in melanoma patients

Aoude, Lauren G., Wong, Bernadette, Bonazzi, Vanessa F, Brosda, Sandra, Walters, Shaun B., Koufariotis, Lambros T., Naeini, Marjan M., Pearson, John V, Oey, Harald, Patel, Kalpana, Bradford, Julia J., Bloxham, Conor J, Atkinson, Victoria, Law, Phillip, Strutton, Geoffrey, Bayley, Gerard, Yang, Samuel, Smithers, B. Mark, Waddell, Nicola, Miles, Kenneth and Barbour, Andrew P. (2021). Radiomics biomarkers correlate with CD8 expression and predict immune signatures in melanoma patients. Molecular Cancer Research, 19 (6) molcanres.1038.2020, 950-956. doi: 10.1158/1541-7786.mcr-20-1038

Human CD141+ dendritic cells (cDC1) are impaired in patients with advanced melanoma but can be targeted to enhance anti-PD-1 in a humanized mouse model

Lee, Yoke Seng, O'Brien, Liam J., Walpole, Carina M., Pearson, Frances E., Leal-Rojas, Ingrid M., Masterman, Kelly-Anne, Atkinson, Victoria, Barbour, Andrew and Radford, Kristen J. (2021). Human CD141+ dendritic cells (cDC1) are impaired in patients with advanced melanoma but can be targeted to enhance anti-PD-1 in a humanized mouse model. Journal for ImmunoTherapy of Cancer, 9 (3) e001963, 1-12. doi: 10.1136/jitc-2020-001963

Complications and survival after hybrid and fully minimally invasive oesophagectomy

Veenstra, M. M. K., Smithers, B. M., Visser, E., Edholm, D., Brosda, S., Thomas, J. M., Gotley, D. C., Thomson, I. G., Wijnhoven, B. P. L. and Barbour, A. P. (2021). Complications and survival after hybrid and fully minimally invasive oesophagectomy. BJS Open, 5 (1) zraa033, 1-7. doi: 10.1093/bjsopen/zraa033

Targeting DNA damage response and replication stress in pancreatic cancer

Dreyer, Stephan B., Upstill-Goddard, Rosie, Paulus-Hock, Viola, Paris, Clara, Lampraki, Eirini-Maria, Dray, Eloise, Serrels, Bryan, Caligiuri, Giuseppina, Rebus, Selma, Plenker, Dennis, Galluzzo, Zachary, Brunton, Holly, Cunningham, Richard, Tesson, Mathias, Nourse, Craig, Bailey, Ulla-Maja, Jones, Marc D., Moran-Jones, Kim, Wright, Derek W., Duthie, Fraser, Oien, Karin, Evers, Lisa, McKay, Colin J., McGregor, Grant A., Gulati, Aditi, Brough, Rachel, Bajrami, Ilirjana, Pettitt, Stephan, Dziubinski, Michele L. ... Sansom, Owen J. (2021). Targeting DNA damage response and replication stress in pancreatic cancer. Gastroenterology, 160 (1), 362-377.e13. doi: 10.1053/j.gastro.2020.09.043

Clinical pathways and outcomes of patients with Barrett’s esophagus in tertiary care settings: a prospective longitudinal cohort study in Australia, 2008–2016

Na, Renhua, Miura, Kyoko, O’Brien, Suzanne, Eslick, Guy D., Kendall, Bradley J., Hourigan, Luke F., Bourke, Michael, Cox, Michael R., Farrokhzadi, Laal, Levert-Mignon, Angelique J., Barbour, Andrew P., Clemons, Nicholas J., Duong, Cuong P., Lord, Reginald V., Phillips, Wayne A., Watson, David I. and Whiteman, David C. (2020). Clinical pathways and outcomes of patients with Barrett’s esophagus in tertiary care settings: a prospective longitudinal cohort study in Australia, 2008–2016. Diseases of the Esophagus, 34 (8) doaa119. doi: 10.1093/dote/doaa119

A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns

Jiao, Wei, Atwal, Gurnit, Polak, Paz, Karlic, Rosa, Cuppen, Edwin, Al-Shahrour, Fatima, Atwal, Gurnit, Bailey, Peter J., Biankin, Andrew V., Boutros, Paul C., Campbell, Peter J., Chang, David K., Cooke, Susanna L., Deshpande, Vikram, Faltas, Bishoy M., Faquin, William C., Garraway, Levi, Getz, Gad, Grimmond, Sean M., Haider, Syed, Hoadley, Katherine A., Jiao, Wei, Kaiser, Vera B., Karlic, Rosa, Kato, Mamoru, Kübler, Kirsten, Lazar, Alexander J., Li, Constance H., Louis, David N. ... von Mering, Christian (2020). A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns. Nature Communications, 11 (1) 728. doi: 10.1038/s41467-019-13825-8

Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples (Nature Communications, (2020), 11, 1, (4748), 10.1038/s41467-020-18151-y)

Bailey, Matthew H., Meyerson, William U., Dursi, Lewis Jonathan, Wang, Liang-Bo, Dong, Guanlan, Liang, Wen-Wei, Weerasinghe, Amila, Li, Shantao, Li, Yize, Kelso, Sean, Akbani, Rehan, Anur, Pavana, Bailey, Matthew H., Buchanan, Alex, Chiotti, Kami, Covington, Kyle, Creason, Allison, Ding, Li, Ellrott, Kyle, Fan, Yu, Foltz, Steven, Getz, Gad, Hale, Walker, Haussler, David, Hess, Julian M., Hutter, Carolyn M., Kandoth, Cyriac, Kasaian, Katayoon, Kasapi, Melpomeni ... von Mering, Christian (2020). Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples (Nature Communications, (2020), 11, 1, (4748), 10.1038/s41467-020-18151-y). Nature Communications, 11 (1) 6232. doi: 10.1038/s41467-020-20128-w

Divergent mutational processes distinguish hypoxic and normoxic tumours

Bhandari, Vinayak, Li, Constance H., Bristow, Robert G., Boutros, Paul C., Aaltonen, Lauri A., Abascal, Federico, Abeshouse, Adam, Aburatani, Hiroyuki, Adams, David J., Agrawal, Nishant, Ahn, Keun Soo, Ahn, Sung-Min, Aikata, Hiroshi, Akbani, Rehan, Akdemir, Kadir C., Al-Ahmadie, Hikmat, Al-Sedairy, Sultan T., Al-Shahrour, Fatima, Alawi, Malik, Albert, Monique, Aldape, Kenneth, Alexandrov, Ludmil B., Ally, Adrian, Alsop, Kathryn, Alvarez, Eva G., Amary, Fernanda, Amin, Samirkumar B., Aminou, Brice, Ammerpohl, Ole ... von Mering, Christian (2020). Divergent mutational processes distinguish hypoxic and normoxic tumours. Nature Communications, 11 (1) 737. doi: 10.1038/s41467-019-14052-x

Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig

Rubanova, Yulia, Shi, Ruian, Harrigan, Caitlin F., Li, Roujia, Wintersinger, Jeff, Sahin, Nil, Deshwar, Amit G., Dentro, Stefan C., Leshchiner, Ignaty, Gerstung, Moritz, Jolly, Clemency, Haase, Kerstin, Tarabichi, Maxime, Wintersinger, Jeff, Deshwar, Amit G., Yu, Kaixian, Gonzalez, Santiago, Rubanova, Yulia, Macintyre, Geoff, Adams, David J., Anur, Pavana, Beroukhim, Rameen, Boutros, Paul C., Bowtell, David D., Campbell, Peter J., Cao, Shaolong, Christie, Elizabeth L., Cmero, Marek, Cun, Yupeng ... von Mering, Christian (2020). Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig. Nature Communications, 11 (1) 731. doi: 10.1038/s41467-020-14352-7

Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples

Bailey, Matthew H., Meyerson, William U., Dursi, Lewis Jonathan, Wang, Liang-Bo, Dong, Guanlan, Liang, Wen-Wei, Weerasinghe, Amila, Li, Shantao, Kelso, Sean, Akbani, Rehan, Anur, Pavana, Bailey, Matthew H., Buchanan, Alex, Chiotti, Kami, Covington, Kyle, Creason, Allison, Ding, Li, Ellrott, Kyle, Fan, Yu, Foltz, Steven, Getz, Gad, Hale, Walker, Haussler, David, Hess, Julian M., Hutter, Carolyn M., Kandoth, Cyriac, Kasaian, Katayoon, Kasapi, Melpomeni, Larson, Dave ... von Mering, Christian (2020). Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples. Nature Communications, 11 (1) 4748. doi: 10.1038/s41467-020-18151-y

Sex differences in oncogenic mutational processes

Li, Constance H., Prokopec, Stephenie D., Sun, Ren X., Yousif, Fouad, Schmitz, Nathaniel, Al-Shahrour, Fatima, Atwal, Gurnit, Bailey, Peter J., Biankin, Andrew V., Boutros, Paul C., Campbell, Peter J., Chang, David K., Cooke, Susanna L., Deshpande, Vikram, Faltas, Bishoy M., Faquin, William C., Garraway, Levi, Getz, Gad, Grimmond, Sean M., Haider, Syed, Hoadley, Katherine A., Jiao, Wei, Kaiser, Vera B., Karlić, Rosa, Kato, Mamoru, Kübler, Kirsten, Lazar, Alexander J., Li, Constance H., Louis, David N. ... Lakhani, Sunil R. (2020). Sex differences in oncogenic mutational processes. Nature Communications, 11 (1) 4330. doi: 10.1038/s41467-020-17359-2

Pathogenic germline variants are associated with poor survival in stage III/IV melanoma patients

Aoude, Lauren G., Bonazzi, Vanessa F., Brosda, Sandra, Patel, Kalpana, Koufariotis, Lambros T., Oey, Harald, Nones, Katia, Wood, Scott, Pearson, John V., Lonie, James M., Arneil, Melissa, Atkinson, Victoria, Smithers, B. Mark, Waddell, Nicola and Barbour, Andrew P. (2020). Pathogenic germline variants are associated with poor survival in stage III/IV melanoma patients. Scientific Reports, 10 (1) 17687, 17687. doi: 10.1038/s41598-020-74956-3

Factors predicting toxicity and response following isolated limb infusion for melanoma: an international multi-centre study

Kenyon-Smith, Timothy J., Kroon, Hidde M., Miura, John T., Teras, Jüri, Beasley, Georgia M., Mullen, Dean, Farrow, Norma E., Mosca, Paul J., Lowe, Michael C., Farley, Clara R., Potdar, Aishwarya, Daou, Hala, Sun, James, Farma, Jeffrey M., Henderson, Michael A., Speakman, David, Serpell, Jonathan, Delman, Keith A., Smithers, B. Mark, Barbour, Andrew, Coventry, Brendon J., Tyler, Douglas S., Zager, Jonathan S. and Thompson, John F. (2020). Factors predicting toxicity and response following isolated limb infusion for melanoma: an international multi-centre study. European Journal of Surgical Oncology, 46 (11), 2140-2146. doi: 10.1016/j.ejso.2020.06.040

HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer

Brunton, Holly, Caligiuri, Giuseppina, Cunningham, Richard, Upstill-Goddard, Rosie, Bailey, Ulla-Maja, Garner, Ian M., Nourse, Craig, Dreyer, Stephan, Jones, Marc, Moran-Jones, Kim, Wright, Derek W., Paulus-Hock, Viola, Nixon, Colin, Thomson, Gemma, Jamieson, Nigel B., McGregor, Grant A., Evers, Lisa, McKay, Colin J., Gulati, Aditi, Brough, Rachel, Bajrami, Ilirjana, Pettitt, Stephen J., Dziubinski, Michele L., Barry, Simon T., Grützmann, Robert, Brown, Robert, Curry, Edward, Allison, Sarah, Biankin, Andrew V. ... Australian Pancreatic Cancer Genome Initiative (2020). HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer. Cell Reports, 31 (6) 107625, 1-28. doi: 10.1016/j.celrep.2020.107625

Australasian Gastrointestinal Trials Group (AGITG) and Trans-Tasman Radiation Oncology Group (TROG) guidelines for pancreatic stereotactic body radiation therapy (SBRT)

Oar, Andrew, Lee, Mark, Le, Hien, Hruby, George, Dalfsen, Raymond, Pryor, David, Lee, Dominique, Chu, Julie, Holloway, Lois, Briggs, Adam, Barbour, Andrew, Chander, Sarat, Ng, Sweet Ping, Samra, Jas, Shakeshaft, John, Goldstein, David, Nguyen, Nam, Goodman, Karyn A., Chang, Daniel T. and Kneebone, Andrew (2020). Australasian Gastrointestinal Trials Group (AGITG) and Trans-Tasman Radiation Oncology Group (TROG) guidelines for pancreatic stereotactic body radiation therapy (SBRT). Practical Radiation Oncology, 10 (3), e136-e146. doi: 10.1016/j.prro.2019.07.018

Management of early-stage gastro-esophageal cancers: expert perspectives from the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty

Roy, Amitesh C., Shapiro, Jeremy, Burge, Matt, Karapetis, Christos S., Pavlakis, Nick, Segelov, Eva, Chau, Ian, Lordick, Florian, Chen, Li-Tong, Barbour, Andrew, Tebbutt, Niall and Price, Tim (2020). Management of early-stage gastro-esophageal cancers: expert perspectives from the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty. Expert Review of Anticancer Therapy, 20 (4), 305-324. doi: 10.1080/14737140.2020.1746185

International multicenter experience of isolated limb infusion for in-transit melanoma metastases in octogenarian and nonagenarian patients

Teras, Jüri, Kroon, Hidde M., Miura, John T., Kenyon-Smith, Tim, Beasley, Georgia M., Mullen, Dean, Farrow, Norma E., Mosca, Paul J., Lowe, Michael C., Farley, Clara R., Potdar, Aishwarya, Daou, Hala, Sun, James, Carr, Michael, Farma, Jeffrey M., Henderson, Michael A., Speakman, David, Serpell, Jonathan, Delman, Keith A., Smithers, B. Mark, Barbour, Andrew, Tyler, Douglas S., Coventry, Brendon J., Zager, Jonathan S. and Thompson, John F. (2020). International multicenter experience of isolated limb infusion for in-transit melanoma metastases in octogenarian and nonagenarian patients. Annals of Surgical Oncology, 27 (5), 1420-1429. doi: 10.1245/s10434-020-08312-0

Pan-cancer analysis of whole genomes

Campbell, Peter J., Getz, Gad, Korbel, Jan O., Stuart, Joshua M., Jennings, Jennifer L., Stein, Lincoln D., Perry, Marc D., Nahal-Bose, Hardeep K., Ouellette, B. F. Francis, Li, Constance H., Rheinbay, Esther, Nielsen, G. Petur, Sgroi, Dennis C., Wu, Chin-Lee, Faquin, William C., Deshpande, Vikram, Boutros, Paul C., Lazar, Alexander J., Hoadley, Katherine A., Louis, David N., Dursi, L. Jonathan, Yung, Christina K., Bailey, Matthew H., Saksena, Gordon, Raine, Keiran M., Buchhalter, Ivo, Kleinheinz, Kortine, Schlesner, Matthias, Zhang, Junjun ... Hamdy, Freddie C. (2020). Pan-cancer analysis of whole genomes. Nature, 578 (7793), 82-93. doi: 10.1038/s41586-020-1969-6

Preoperative cisplatin, fluorouracil, and docetaxel with or without radiotherapy after poor early response to cisplatin and fluorouracil for resectable oesophageal adenocarcinoma (AGITG DOCTOR): results from a multicentre, randomised controlled phase II trial

Barbour, A P, Walpole, E T, Mai, G T, Barnes, E H, Watson, D I, Ackland, S P, Martin, J M, Burge, M, Finch, R, Karapetis, C S, Shannon, J, Nott, L M, Varma, S, Marx, G, Falk, G L, Gebski, V, Oostendorp, M, Wilson, K, Thomas, J, Lampe, G, Zalcberg, J R, Simes, J, Smithers, B M and DOCTOR investigators (2020). Preoperative cisplatin, fluorouracil, and docetaxel with or without radiotherapy after poor early response to cisplatin and fluorouracil for resectable oesophageal adenocarcinoma (AGITG DOCTOR): results from a multicentre, randomised controlled phase II trial. Annals of Oncology, 31 (2), 236-245. doi: 10.1016/j.annonc.2019.10.019

The AGITG GAP study: a phase II study of perioperative gemcitabine and nab-paclitaxel for resectable pancreas cancer

Barbour, Andrew P., Samra, Jaswinder S., Haghighi, Koroush S., Donoghoe, Mark W., Burge, Matthew, Harris, Marion T., Chua, Yu Jo, Mitchell, Jenna, O’Rourke, Nick, Chan, Howard, Gebski, Val J., Gananadha, Sivakumar, Croagh, Daniel G., Kench, James G., Goldstein, David, Barbour, A., Goldstein, D., Samra, J. S., Harris, M., Chua, Y. J., O’Rourke, N., Yip, S., Gebski, V., Simes, J., Hicks, R., Coates, A., Gurney, H., Do, V., Marschner, I. ... Jones, R. (2020). The AGITG GAP study: a phase II study of perioperative gemcitabine and nab-paclitaxel for resectable pancreas cancer. Annals of Surgical Oncology, 27 (7), 2506-2515. doi: 10.1245/s10434-020-08205-2

Effective targeting of intact and proteolysed CDCP1 for imaging and treatment of pancreatic ductal adenocarcinoma

Kryza, Thomas, Khan, Tashbib, Puttick, Simon, Li, Chao, Sokolowski, Kamil A., Tse, Brian W.C., Cuda, Tahleesa, Lyons, Nicholas, Gough, Madeline, Yin, Julia, Parkin, Ashleigh, Deryugina, Elena I., Quigley, James P., Law, Ruby H.P., Whisstock, James C., Riddell, Andrew D., Barbour, Andrew P., Wyld, David K., Thomas, Paul A., Rose, Stephen, Snell, Cameron E., Pajic, Marina, He, Yaowu and Hooper, John D. (2020). Effective targeting of intact and proteolysed CDCP1 for imaging and treatment of pancreatic ductal adenocarcinoma. Theranostics, 10 (9), 4116-4133. doi: 10.7150/thno.43589

Baseline neutrophil–lymphocyte ratio holds no prognostic value for esophageal and junctional adenocarcinoma in patients treated with neoadjuvant chemotherapy

van Hootegem, S. J. M., Smithers, B. M., Gotley, D. C., Brosda, S., Thomson, I. G., Thomas, J. M., Gartside, M. and Barbour, A. P. (2019). Baseline neutrophil–lymphocyte ratio holds no prognostic value for esophageal and junctional adenocarcinoma in patients treated with neoadjuvant chemotherapy. Diseases of the Esophagus, 33 (6). doi: 10.1093/dote/doz082

The impact of signet ring cell differentiation on outcome in patients with esophageal and gastroesophageal junction adenocarcinoma

van Hootegem, Sander J. M., Smithers, B. Mark, Gotley, David C., Brosda, Sandra, Thomson, Iain G., Thomas, Janine M., Gartside, Michael, van Lanschot, Jan J. B., Lagarde, Sjoerd M., Wijnhoven, Bas P. L. and Barbour, Andrew P. (2019). The impact of signet ring cell differentiation on outcome in patients with esophageal and gastroesophageal junction adenocarcinoma. Annals of Surgical Oncology, 26 (8), 2375-2384. doi: 10.1245/s10434-019-07322-x

CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan

Vennin, Claire, Melenec, Pauline, Rouet, Romain, Nobis, Max, Cazet, Aurelie S., Murphy, Kendelle J., Herrmann, David, Reed, Daniel A., Lucas, Morghan C., Warren, Sean C., Elgundi, Zehra, Pinese, Mark, Kalna, Gabriella, Roden, Daniel, Samuel, Monisha, Zaratzian, Anaiis, Grey, Shane T., Da Silva, Andrew, Leung, Wilfred, Mathivanan, Suresh, Wang, Yingxiao, Braithwaite, Anthony W., Christ, Daniel, Benda, Ales, Parkin, Ashleigh, Phillips, Phoebe A., Whitelock, John M., Gill, Anthony J., Sansom, Owen J. ... Australian Pancreatic Genome Initiative (APGI) (2019). CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan. Nature Communications, 10 (1) 3637. doi: 10.1038/s41467-019-10968-6

Evaluation of the efficacy and toxicity of upper extremity isolated limb infusion chemotherapy for melanoma: an Australian multi-center study

Kroon, Hidde M., Coventry, Brendon J., Henderson, Michael A., Barbour, Andrew, Serpell, Jonathan, Smithers, B. Mark and Thompson, John F. (2019). Evaluation of the efficacy and toxicity of upper extremity isolated limb infusion chemotherapy for melanoma: an Australian multi-center study. European Journal of Surgical Oncology, 45 (5), 832-837. doi: 10.1016/j.ejso.2019.02.026

To be or not to be: Non-invasive screening for Barrett’s esophagus, dysplasia and adenocarcinoma

Shah, Alok K., Joshi, Virendra, Hartel, Gunter, Barbour, Andrew P. and Hill, Michelle M. (2019). To be or not to be: Non-invasive screening for Barrett’s esophagus, dysplasia and adenocarcinoma. Translational Gastroenterology and Hepatology, 4 (May) 31, 31-31. doi: 10.21037/tgh.2019.04.08

Complex structural rearrangements are present in high-grade dysplastic Barrett's oesophagus samples

Newell, Felicity, Patel, Kalpana, Gartside, Michael, Krause, Lutz, Brosda, Sandra, Aoude, Lauren G., Loffler, Kelly A., Bonazzi, Vanessa F., Patch, Ann-Marie, Kazakoff, Stephen H., Holmes, Oliver, Xu, Qinying, Wood, Scott, Leonard, Conrad, Lampe, Guy, Lord, Reginald V., Whiteman, David C., Pearson, John V., Nones, Katia, Waddell, Nicola and Barbour, Andrew P. (2019). Complex structural rearrangements are present in high-grade dysplastic Barrett's oesophagus samples. BMC Medical Genomics, 12 (1) 31, 31. doi: 10.1186/s12920-019-0476-9

Patients with in-transit melanoma metastases have comparable survival outcomes following isolated limb infusion or intralesional PV-10-A propensity score matched, single center study

Read, Tavis, Fayers, Warren, Thomas, Janine, Wagels, Michael, Barbour, Andrew and Smithers, B. Mark (2019). Patients with in-transit melanoma metastases have comparable survival outcomes following isolated limb infusion or intralesional PV-10-A propensity score matched, single center study. Journal of Surgical Oncology, 119 (6), 717-727. doi: 10.1002/jso.25373

Evaluation of serum glycoprotein biomarker candidates for detection of esophageal adenocarcinoma and surveillance of Barrett’s esophagus

Shah, Alok K., Hartel, Gunter, Brown, Ian, Winterford, Clay, Na, Renhua, Lê Cao, Kim-Anh, Spicer, Bradley A., Dunstone, Michelle A., Phillips, Wayne A, Lord, Reginald V., Barbour, Andrew P., Watson, David I., Joshi, Virendra, Whiteman, David C. and Hill, Michelle M. (2018). Evaluation of serum glycoprotein biomarker candidates for detection of esophageal adenocarcinoma and surveillance of Barrett’s esophagus. Molecular and Cellular Proteomics, 17 (12), 2324-2334. doi: 10.1074/mcp.ra118.000734

Patterns of failure following dose-escalated chemoradiotherapy for fluorodeoxyglucose positron emission tomography staged squamous cell carcinoma of the oesophagus

Effeney, R., Shaw, T., Burmeister, B. H., Burmeister, E., Harvey, J., Mai, G. T., Thomas, J., Barbour, A. P., Smithers, B. M. and Pryor, D. I. (2018). Patterns of failure following dose-escalated chemoradiotherapy for fluorodeoxyglucose positron emission tomography staged squamous cell carcinoma of the oesophagus. Clinical Oncology, 30 (10), 642-649. doi: 10.1016/j.clon.2018.06.011

Neoadjuvant chemotherapy or chemoradiotherapy for adenocarcinoma of the esophagus

Visser, Els, Edholm, David, Smithers, B. Mark, Thomson, Iain G., Burmeister, Bryan H., Walpole, Euan T., Gotley, David C., Joubert, Warren L., Atkinson, Victoria, Mai, Tao, Thomas, Janine M. and Barbour, Andrew P. (2018). Neoadjuvant chemotherapy or chemoradiotherapy for adenocarcinoma of the esophagus. Journal of Surgical Oncology, 117 (8), 1687-1696. doi: 10.1002/jso.25089

Neoadjuvant therapy reduces cardiopulmunary function in patients undegoing oesophagectomy

Thomson, Iain G., Wallen, Matthew P., Hall, Adrian, Ferris, Rebekah, Gotley, David C., Barbour, Andrew P., Lee, Andrew, Thomas, Janine and Smithers, Bernard M. (2018). Neoadjuvant therapy reduces cardiopulmunary function in patients undegoing oesophagectomy. International Journal of Surgery, 53, 86-92. doi: 10.1016/j.ijsu.2018.03.030

Intralesional PV-10 for the treatment of in-transit melanoma metastases-Results of a prospective, non-randomized, single center study

Read, Tavis A., Smith, Aaron, Thomas, Janine, David, Michael, Foote, Matthew, Wagels, Michael, Barbour, Andrew and Smithers, B. Mark (2018). Intralesional PV-10 for the treatment of in-transit melanoma metastases-Results of a prospective, non-randomized, single center study. Journal of Surgical Oncology, 117 (4), 579-587. doi: 10.1002/jso.24921

Breaking bad conduits: 'resleeving' the intrathoracic gastric conduit post oesophagectomy

Evennett, Nicholas J. and Barbour, Andrew P. (2018). Breaking bad conduits: 'resleeving' the intrathoracic gastric conduit post oesophagectomy. ANZ Journal of Surgery, 88 (3), E222-E223. doi: 10.1111/ans.13337

Genomic Perturbations Reveal Distinct Regulatory Networks in Intrahepatic Cholangiocarcinoma

Nepal, Chirag, O'Rourke, Colm J., Oliveira, Douglas Vnp, Taranta, Andrzej, Shema, Steven, Gautam, Prson, Calderaro, Julien, Barbour, Andrew, Raggi, Chiara, Wennerberg, Krister, Wang, Xin W., Lautem, Anja, Roberts, Lewis R. and Andersen, Jesper B. (2017). Genomic Perturbations Reveal Distinct Regulatory Networks in Intrahepatic Cholangiocarcinoma. Hepatology (Baltimore, Md.), 68 (3), 949-963. doi: 10.1002/hep.29764

Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer

Balachandran, Vinod P., Łuksza, Marta, Zhao, Julia N., Makarov, Vladimir, Moral, John Alec, Remark, Romain, Herbst, Brian, Askan, Gokce, Bhanot, Umesh, Senbabaoglu, Yasin, Wells, Daniel K., Cary, Charles Ian Ormsby, Grbovic-Huezo, Olivera, Attiyeh, Marc, Medina, Benjamin, Zhang, Jennifer, Loo, Jennifer, Saglimbeni, Joseph, Abu-Akeel, Mohsen, Zappasodi, Roberta, Riaz, Nadeem, Smoragiewicz, Martin, Larkin Kelley, Z., Basturk, Olca, Gönen, Mithat, Levine, Arnold J., Allen, Peter J., Fearon, Douglas T., Merad, Miriam ... Bassi, Claudio (2017). Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer. Nature, 551 (7681), 512-516. doi: 10.1038/nature24462

Safety and Efficacy of Isolated Limb Infusion Chemotherapy for Advanced Locoregional Melanoma in Elderly Patients: An Australian Multicenter Study

Kroon, Hidde M., Coventry, Brendon J., Giles, Mitchell H., Henderson, Michael A., Speakman, David, Wall, Mark, Barbour, Andrew, Serpell, Jonathan, Paddle, Paul, Smithers, Bernard M. and Thompson, John F. (2017). Safety and Efficacy of Isolated Limb Infusion Chemotherapy for Advanced Locoregional Melanoma in Elderly Patients: An Australian Multicenter Study. Annals of Surgical Oncology, 24 (11), 3245-3251. doi: 10.1245/s10434-017-6046-5

When is a sentinel node biopsy indicated for patients with primary melanoma? An update of the 'Australian guidelines for the management of cutaneous melanoma'

Gyorki, David E., Barbour, Andrew, Hanikeri, Mark, Mar, Victoria, Sandhu, Shahneen and Thompson, John F. (2017). When is a sentinel node biopsy indicated for patients with primary melanoma? An update of the 'Australian guidelines for the management of cutaneous melanoma'. Australasian Journal of Dermatology, 58 (4), 274-277. doi: 10.1111/ajd.12662

Primary cutaneous melanoma of the scalp: Patterns of recurrence

Sparks, David S., Read, Tavis, Lonne, Michael, Barbour, Andrew P., Wagels, Michael, Bayley, Gerard J. and Smithers, B. Mark (2017). Primary cutaneous melanoma of the scalp: Patterns of recurrence. Journal of Surgical Oncology, 115 (4), 449-454. doi: 10.1002/jso.24535

Whole-genome landscape of pancreatic neuroendocrine tumours

Scarpa, Aldo, Chang, David K., Nones, Katia, Corbo, Vincenzo, Patch, Ann-Marie, Bailey, Peter, Lawlor, Rita T., Johns, Amber L., Miller, David K., Mafficini, Andrea, Rusev, Borislav, Scardoni, Maria, Antonello, Davide, Barbi, Stefano, Sikora, Katarzyna O., Cingarlini, Sara, Vicentini, Caterina, McKay, Skye, Quinn, Michael C.J., Bruxner, Timothy J.C., Christ, Angelika N., Harliwong, Ivon, Idrisoglu, Senel, McLean, Suzanne, Nourse, Craig, Nourbakhsh, Ehsan, Wilson, Peter J., Anderson, Matthew J., Fink, J. Lynn ... Grimmond, Sean M. (2017). Whole-genome landscape of pancreatic neuroendocrine tumours. Nature, 543 (7643), 65-71. doi: 10.1038/nature21063

Corrigendum: Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance

Secrier, Maria, Li, Xiaodun, de Silva, Nadeera, Eldridge, Matthew D., Contino, Gianmarco, Bornschein, Jan, MacRae, Shona, Grehan, Nicola, O'Donovan, Maria, Miremadi, Ahmad, Yang, Tsun-Po, Bower, Lawrence, Chettouh, Hamza, Crawte, Jason, Galeano-Dalmau, Núria, Grabowska, Anna, Saunders, John, Underwood, Tim, Waddell, Nicola, Barbour, Andrew P., Nutzinger, Barbara, Achilleos, Achilleas, Edwards, Paul A W, Lynch, Andy G., Tavaré, Simon and Fitzgerald, Rebecca C. (2017). Corrigendum: Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance. Nature Genetics, 49 (2), 317-317. doi: 10.1038/ng0217-317a

Hypermutation in pancreatic cancer

Humphris, Jeremy L., Patch, Ann-Marie, Nones, Katia, Bailey, Peter J., Johns, Amber L., McKay, Skye, Chang, David K., Miller, David K., Pajic, Marina, Kassahn, Karin S., Quinn, Michael C. J., Bruxner, Timothy J. C., Christ, Angelika N., Harliwong, Ivon, Idrisoglu, Senel, Manning, Suzanne, Nourse, Craig, Nourbakhsh, Ehsan, Stone, Andrew, Wilson, Peter J., Anderson, Matthew, Fink, J. Lynn, Holmes, Oliver, Kazakoff, Stephen, Leonard, Conrad, Newell, Felicity, Waddell, Nick, Wood, Scott, Mead, Ronald S. ... Biankin, Andrew V. (2017). Hypermutation in pancreatic cancer. Gastroenterology, 152 (1), 68-74.e2. doi: 10.1053/j.gastro.2016.09.060

Identification of the CIMP-like subtype and aberrant methylation of members of the chromosomal segregation and spindle assembly pathways in esophageal adenocarcinoma

Krause, Lutz, Nones, Katia , Loffler, Kelly A., Nancarrow, Derek, Oey, Harald , Tang, Yue Hang, Wayte, Nicola J., Patch, Ann Marie, Patel, Kalpana , Brosda, Sandra, Manning, Suzanne, Lampe, Guy, Clouston, Andrew, Thomas, Janine, Stoye, Jens, Hussey, Damian J., Watson, David I., Lord, Reginald V., Phillips, Wayne A., Gotley, David, Smithers, B. Mark, Whiteman, David C., Hayward, Nicholas K., Grimmond, Sean M., Waddell, Nicola and Barbour, Andrew P. (2016). Identification of the CIMP-like subtype and aberrant methylation of members of the chromosomal segregation and spindle assembly pathways in esophageal adenocarcinoma. Carcinogenesis, 37 (4), 356-365. doi: 10.1093/carcin/bgw018

Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance

Secrier, Maria, Li, Xiaodun, De Silva, Nadeera, Eldridge, Matthew D., Contino, Gianmarco, Bornschein, Jan, Macrae, Shona, Grehan, Nicola, O'Donovan, Maria, Miremadi, Ahmad, Yang, Tsun-Po, Bower, Lawrence, Chettouh, Hamza, Crawte, Jason, Galeano-Dalmau, Núria, Grabowska, Anna, Saunders, John, Underwood, Tim, Waddell, Nicola, Barbour, Andrew P., Nutzinger, Barbara, Achilleos, Achilleas, Edwards, Paul A. W., Lynch, Andy G., Tavare, Simon, Fitzgerald, Rebecca C., Noorani, Ayesha, Elliott, Rachael Fels, Weaver, Jamie ... Grimmond, Sean M. (2016). Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance. Nature Genetics, 48 (10), 1131-1141. doi: 10.1038/ng.3659

Molecular markers to complement sentinel node status in predicting survival in patients with high-risk locally invasive melanoma

Rowe, Casey J., Tang, Fiona, Hughes, Maria Celia B., Rodero, Mathieu P., Malt, Maryrose, Lambie, Duncan, Barbour, Andrew, Hayward, Nicholas K., Smithers, B. Mark, Green, Adele C. and Khosrotehrani, Kiarash (2016). Molecular markers to complement sentinel node status in predicting survival in patients with high-risk locally invasive melanoma. International Journal of Cancer, 139 (3), 664-672. doi: 10.1002/ijc.30085

Refining the care of patients with pancreatic cancer: the AGITG pancreatic cancer workshop consensus

Gandy, Robert C., Barbour, Andrew P., Samra, Jaswinder, Nikfarjam, Mehrdad, Haghighi, Koroush, Kench, James G., Saxena, Payal and Goldstein, David (2016). Refining the care of patients with pancreatic cancer: the AGITG pancreatic cancer workshop consensus. Medical Journal of Australia, 204 (11), 419-422. doi: 10.5694/mja16.00061

Glyco-centric lectin magnetic bead array (LeMBA) - proteomics dataset of human serum samples from healthy, Barrett's esophagus and esophageal adenocarcinoma individuals

Shah, Alok K., Le Cao, Kim-Anh, Choi, Eunju, Chen, David, Gautier, Benoit, Nancarrow, Derek, Whiteman, David C., Baker, Peter R., Clauser, Karl R., Chalkley, Robert J., Saunders, Nicholas A., Barbour, Andrew P., Joshi, Virendra and Hill, Michelle M. (2016). Glyco-centric lectin magnetic bead array (LeMBA) - proteomics dataset of human serum samples from healthy, Barrett's esophagus and esophageal adenocarcinoma individuals. Data in Brief, 7, 1058-1062. doi: 10.1016/j.dib.2016.03.081

Assessment of morbidity following regional nodal dissection in the axilla and groin for metastatic melanoma

Theodore, Jane E., Frankel, Adam J., Thomas, Janine M., Barbour, Andrew P., Bayley, Gerard J., Allan, Christopher P., Wagels, Michael and Smithers, B. Mark (2016). Assessment of morbidity following regional nodal dissection in the axilla and groin for metastatic melanoma. ANZ journal of surgery, 87 (1-2), 44-48. doi: 10.1111/ans.13526

Australian multicenter study of isolated limb infusion for melanoma

Kroon, Hidde M., Coventry, Brendon J., Giles, Mitchell H., Henderson, Michael A., Speakman, David, Wall, Mark, Barbour, Andrew, Serpell, Jonathan, Paddle, Paul, Coventry, Alexander G. J., Sullivan, Thomas, Smithers, Bernard Mark and Thompson, John F. (2016). Australian multicenter study of isolated limb infusion for melanoma. Annals of Surgical Oncology, 23 (4), 1096-1103. doi: 10.1245/s10434-015-4969-2

Genomic analyses identify molecular subtypes of pancreatic cancer

Baile, Peter, Chang, David K., Nones, Katia, Johns, Amber L., Patch, Ann-Marie, Gingras, Marie-Claude, Miller, David K., Christ, Angelika N., Bruxner, Tim J. C., Quinn, Michael C., Nourse, Craig, Murtaugh, L. Charles, Harliwong, Ivon, Idrisoglu, Senel, Manning, Suzanne, Nourbakhsh, Ehsan, Wani, Shivangi, Fink, Lynn, Holmes, Oliver, Chin, Vencssa, Anderson, Matthew J., Kazakoff, Stephen, Leonard, Conrad, Newell, Felicity, Waddell, Nick, Wood, Scott, Xu, Qinying, Wilson, Peter J., Cloonan, Nicole ... Grimmond, Sean M. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531 (7592), 47-52. doi: 10.1038/nature16965

Genomics of pancreatic tumours - what we now know

Patch, Ann-Marie, Barbour, Andrew and Waddell, Nicola (2016). Genomics of pancreatic tumours - what we now know. Cancer Forum, 40 (1), 6-10.

Pancreatic cancer: is the surgeon still relevant?

Butler, Nick, Samra, Jaswinder, Nikfarjam, Mehrdad and Barbour, Andrew P. (2016). Pancreatic cancer: is the surgeon still relevant?. Cancer Forum, 40 (1), 39-42.

Sentinel node biopsy in patients with intermediate and thick melanomas - A balanced view

Saw, Robyn, Allan, Christopher, Barbour, Andrew, Ch'ng, Sydney, Coventry, Brendon J., Gyorki, David, Henderson, Michael, Howle, Julie, Hughes, T. Michael, Lee, Kenneth, Neuhaus, Susan, Saunders, Christobel, Shannon, Kerwin, Smithers, Mark, Speakman, David, Spillane, John and Stretch, Jonathan (2015). Sentinel node biopsy in patients with intermediate and thick melanomas - A balanced view. Australian Family Physician, 44 (12), 876-876.

Meta-analysis of radical resection rates and margin assessment in pancreatic cancer

Chandrasegaram, M. D., Goldstein, D., Simes, J., Gebski, V., Kench, J. G., Gill, A. J., Samra, J. S., Merrett, N. D., Richardson, A. J. and Barbour, A. P. (2015). Meta-analysis of radical resection rates and margin assessment in pancreatic cancer. British Journal of Surgery, 102 (12), 1459-1472. doi: 10.1002/bjs.9892

Serum glycoprotein biomarker discovery and qualification pipeline reveals novel diagnostic biomarker candidates for esophageal adenocarcinoma

Shah, Alok K., Le Cao, Kim-Anh, Choi, Eunju, Chen, David, Gautier, Benoit, Nancarrow, Derek, Whiteman, David C., Saunders, Nicholas A., Barbour, Andrew P., Joshi, Virendra and Hill, Michelle M. (2015). Serum glycoprotein biomarker discovery and qualification pipeline reveals novel diagnostic biomarker candidates for esophageal adenocarcinoma. Molecular and Cellular Proteomics, 14 (11), 3023-3039. doi: 10.1074/mcp.M115.050922

Prospective study of patterns of surgical management in adults with primary cutaneous melanoma at high risk of spread, in Queensland, Australia

Smithers, B.Mark, Hughes, Maria Celia B., Beesley, Vanessa L., Barbour, Andrew P., Malt, Maryrose K., Weedon, David, Zonta, Mark J., Wood, Dominic J., Triscott, Joseph A., Bayley, Gerard J., Brown, Lee J., Allan, Christopher P., D'Arcy, Justin, Williamson, Richard, Khosrotehrani, Kiarash and Green, Adele C. (2015). Prospective study of patterns of surgical management in adults with primary cutaneous melanoma at high risk of spread, in Queensland, Australia. Journal of Surgical Oncology, 112 (4), 359-365. doi: 10.1002/jso.24013

Two cases of NSAID-induced gastropathy and enteropathy of the ileum

Auld, Michael C., Dodd, Benjamin R., Barbour, Andrew P. and Smithers, Mark (2015). Two cases of NSAID-induced gastropathy and enteropathy of the ileum. ANZ Journal of Surgery, 85 (7-8), 584-585. doi: 10.1111/ans.12462

MicroRNA and mRNA expression profiling in metastatic melanoma reveal associations with BRAF mutation and patient prognosis

Tembe, Varsha, Schramm, Sarah-Jane, Stark, Mitchell, Patrick, Ellis, Jayaswal, Vivek, Tang, Yue Hang, Barbour, Andrew, Hayward, Nicholas K., Thompson, John F., Scolyer, Richard A., Yang, Yee Hwa and Mann, Graham J. (2015). MicroRNA and mRNA expression profiling in metastatic melanoma reveal associations with BRAF mutation and patient prognosis. Pigment Cell and Melanoma Research, 28 (3), 254-266. doi: 10.1111/pcmr.12343

The Prognostic and Predictive Value of Melanoma-related MicroRNAs Using Tissue and Serum: A MicroRNA Expression Analysis

Stark, Mitchell S., Klein, Kerenaftali, Weide, Benjamin, Haydu, Lauren E., Pflugfelder, Annette, Tang, Yue Hang, Palmer, Jane M., Whiteman, David C., Scolyer, Richard A., Mann, Graham J., Thompson, John F., Long, Georgina V., Barbour, Andrew P., Soyer, H. Peter, Garbe, Claus, Herington, Adrian, Pollock, Pamela M. and Hayward, Nicholas K. (2015). The Prognostic and Predictive Value of Melanoma-related MicroRNAs Using Tissue and Serum: A MicroRNA Expression Analysis. EBioMedicine, 2 (7), 671-680. doi: 10.1016/j.ebiom.2015.05.011

Whole genomes redefine the mutational landscape of pancreatic cancer

Waddell, Nicola, Pajic, Marina, Patch, Anne-Marie, Chang, David K, Kassahn, Karin S, Bailey, Peter, Johns, Amber L, Miller, David, Nones, Katia, Quek, Kelly, Quinn, Michael C. J, Robertson, Alan J, Fadlullah, Muhammad Z.H, Bruxner, Tim J.C, Christ, Angelika N, Harliwong, Ivon, Idrisoglu, Senel, Manning, Suzanne, Nourse, Craig, Nourbakhsh, Ehsan, Wani, Shivangi, Wilson, Peter J, Markham, Emma, Cloonan, Nicole, Anderson, Matthew J, Fink, J. Lynn, Holmes, Oliver, Kazakoff, Stephen H, Leonard, Conrad ... Grimmond, Sean M (2015). Whole genomes redefine the mutational landscape of pancreatic cancer. Nature, 518 (7540), 495-501. doi: 10.1038/nature14169

Patterns of recurrence in patients with stage IIIB/C cutaneous melanoma of the head and neck following surgery with and without adjuvant radiation therapy: is isolated regional recurrence salvageable?

Barbour, Samantha, Smithers, B. Mark, Allan, Chris, Bayley, Gerard, Thomas, Janine, Foote, Matthew, Burmeister, Bryan and Barbour, Andrew P. (2015). Patterns of recurrence in patients with stage IIIB/C cutaneous melanoma of the head and neck following surgery with and without adjuvant radiation therapy: is isolated regional recurrence salvageable?. Annals of Surgical Oncology, 22 (12), 4052-4059. doi: 10.1245/s10434-014-4356-4

Genomic catastrophes frequently arise in esophageal adenocarcinoma and drive tumorigenesis

Nones, Katia, Waddell, Nicola, Wayte, Nicci, Patch, Ann-Marie, Bailey, Peter, Newell, Felicity, Holmes, Oliver, Fink, J. Lynn, Quinn, Michael C. J., Tang, Yue Hang, Lampe, Guy, Quek, Kelly, Loffler, Kelly A., Manning, Suzanne, Idrisoglu, Senel, Miller, David, Xu, Qinying, Waddell, Nick, Wilson, Peter J., Bruxner, Timothy J. C., Christ, Angelika N., Harliwong, Ivon, Nourse, Craig, Nourbakhsh, Ehsan, Anderson, Matthew, Kazakoff, Stephen, Leonard, Conrad, Wood, Scott, Simpson, Peter T. ... Barbour, Andrew P. (2014). Genomic catastrophes frequently arise in esophageal adenocarcinoma and drive tumorigenesis. Nature Communications, 5 (1) 6224, 5224.1-5224.9. doi: 10.1038/ncomms6224

Supportive care needs, anxiety, depression and quality of life amongst newly diagnosed patients with localised invasive cutaneous melanoma in Queensland, Australia

Beesley, Vanessa L., Smithers, B. Mark, Khosrotehrani, Kiarash, Khatun, Modsina, O'Rourke, Peter, Hughes, Maria Celia B., Malt, Maryrose K., Zonta, Mark J., Bayley, Gerard J., Barbour, Andrew P., Brown, Lee J., D'Arcy, Justin, Allan, Christopher and Green, Adèle C. (2014). Supportive care needs, anxiety, depression and quality of life amongst newly diagnosed patients with localised invasive cutaneous melanoma in Queensland, Australia. Psycho-Oncology, 24 (7), 763-770. doi: 10.1002/pon.3718

BRAF mutation status is an independent prognostic factor for resected stage IIIB and IIIC melanoma: implications for melanoma staging and adjuvant therapy

Barbour, Andrew P., Tang, Yue Hang, Armour, Nicola, Dutton-Regester, Ken, Krause, Lutz, Loffler, Kelly A., Lambie, Duncan, Burmeister, Bryan, Thomas, Janine, Smithers, B. Mark and Hayward, Nicholas K. (2014). BRAF mutation status is an independent prognostic factor for resected stage IIIB and IIIC melanoma: implications for melanoma staging and adjuvant therapy. European Journal of Cancer, 50 (15), 2668-2676. doi: 10.1016/j.ejca.2014.06.009

Controversies in the management of gastrointestinal stromal tumors

Yip, Desmond, Zalcberg, John, Ackland, Stephen, Barbour, Andrew P., Desai, Jayesh, Fox, Stephen, Kotasek, Dusan, McArthur, Grant and Smithers, B. Mark (2014). Controversies in the management of gastrointestinal stromal tumors. Asia-Pacific Journal of Clinical Oncology, 10 (3), 216-227. doi: 10.1111/ajco.12187

Australian multi-center experience outside of the Sydney Melanoma Unit of isolated limb infusion chemotherapy for melanoma

Coventry, Brendon J., Kroon, Hidde M., Giles, Mitchell H., Henderson, Michael, Speakman, David, Wall, Mark, Barbour, Andrew, Serpell, Jonathan, Paddle, Paul, Coventry, Alexander G.J., Sullivan, Thomas and Smithers, B. Mark (2014). Australian multi-center experience outside of the Sydney Melanoma Unit of isolated limb infusion chemotherapy for melanoma. Journal of Surgical Oncology, 109 (8), 780-785. doi: 10.1002/jso.23590

Nomograms to predict recurrence and survival in stage IIIB and IIIC melanoma after therapeutic lymphadenectomy

Khosrotehrani, Kiarash, van der Ploeg, Augustinus P.T., Siskind,Victor, Hughes, Maria Celia, Wright, Annaliesa, Thomas, Janine, Barbour, Andrew, Allan, Christopher, Bayley, Gerard, Eggermont, Alexander, Verhoef, Cornelis, Smithers, B. Mark and Green, Adele C. (2014). Nomograms to predict recurrence and survival in stage IIIB and IIIC melanoma after therapeutic lymphadenectomy. European Journal of Cancer, 50 (7), 1301-1309. doi: 10.1016/j.ejca.2014.02.010

Genome-wide analysis of esophageal adenocarcinoma yields specific copy number aberrations that correlate with prognosis

Frankel, Adam, Armour, Nicola, Nancarrow, Derek, Krause, Lutz, Hayward, Nicholas, Lampe, Guy, Smithers, B. Mark and Barbour, Andrew (2014). Genome-wide analysis of esophageal adenocarcinoma yields specific copy number aberrations that correlate with prognosis. Genes Chromosomes and Cancer, 53 (4), 324-338. doi: 10.1002/gcc.22143

A case-control study of the role of human papillomavirus in oesophageal squamous cell carcinoma in Australia

Liyanage, Surabhi S., Segelov, Eva, Malik, Aisha, Garland, Suzanne M., Tabrizi, Sepehr N., Cummins, Eleanor, Seale, Holly, Rahman, Bayzidur, Moa, Aye, Barbour, Andrew P., Crowe, Philip J. and Macintyre, C. Raina (2014). A case-control study of the role of human papillomavirus in oesophageal squamous cell carcinoma in Australia. Journal of Oncology, 2014 (Article No. 236482) 236482, 236482-7. doi: 10.1155/2014/236482

Treatment results of curative gastric resection from a specialist Australian unit: Low volume with satisfactory outcomes

Thomson I.G., Gotley D.C., Barbour A.P., Martin I., Jayasuria N., Thomas J. and Smithers B.M. (2014). Treatment results of curative gastric resection from a specialist Australian unit: Low volume with satisfactory outcomes. Gastric Cancer, 17 (1), 152-160. doi: 10.1007/s10120-013-0240-3

Patients undergoing lymphadenectomy for Stage III melanomas of known or unknown primary site do not differ in outcome

Hughes, Maria Celia, Wright, Annaliesa, Barbour, Andrew, Thomas, Janine, Smithers, B. Mark, Green, Adele C. and Khosrotehrani, Kiarash (2013). Patients undergoing lymphadenectomy for Stage III melanomas of known or unknown primary site do not differ in outcome. International Journal of Cancer, 133 (12), 3000-3007. doi: 10.1002/ijc.28318

Early diagnostic biomarkers for esophageal adenocarcinoma: the current state of play

Shah, Alok Kishorkumar, Saunders, Nicholas A., Barbour, Andrew P. and Hill, Michelle M. (2013). Early diagnostic biomarkers for esophageal adenocarcinoma: the current state of play. Cancer Epidemiology: Biomarkers and Prevention, 22 (7), 1185-1209. doi: 10.1158/1055-9965.EPI-12-1415

Role of human papillomaviruses in esophageal squamous cell carcinoma

Liyanage, Surabhi S., Segelov, Eva, Garland, Suzanne M., Tabrizi, Sepehr N., Seale, Holly, Crowe, Philip J., Dwyer, Dominic E., Barbour, Andrew, Newall, Anthony T., Malik, Aisha and Macintyre, C. Raina (2013). Role of human papillomaviruses in esophageal squamous cell carcinoma. Asia-Pacific Journal of Clinical Oncology, 9 (1), 12-28. doi: 10.1111/j.1743-7563.2012.01555.x

Impact of postoperative morbidity on long-term survival after oesophagectomy

Hii, M. W., Smithers, B. M., Gotley, D. C., Thomas, J. M., Thomson, I., Martin, I. and Barbour, A. P. (2013). Impact of postoperative morbidity on long-term survival after oesophagectomy. British Journal of Surgery, 100 (1), 95-104. doi: 10.1002/bjs.8973

Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes

Biankin, Andrew V., Waddell, Nicola, Kassahn, Karin S., Gingras, Marie-Claude, Muthuswamy, Lakshmi B., Johns, Amber L., Miller, David K., Wilson, Peter J., Patch, Ann-Marie, Wu, Jianmin, Chang, David K., Cowley, Mark J., Gardiner, Brooke B., Song, Sarah, Harliwong, Ivon, Idrisoglu, Senel, Nourse, Craig, Nourbakhsh, Ehsan, Manning, Suzanne, Wani, Shivangi, Gongora, Milena, Pajic, Marina, Scarlett, Christopher J., Gill, Anthony J., Pinho, Andreia V., Rooman, Ilse, Anderson, Matthew, Holmes, Oliver, Leonard, Conrad ... Grimmond, Sean M. (2012). Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature, 491 (7424), 399-405. doi: 10.1038/nature11547

Surgical management in patients with pancreatic cancer: a Queensland perspective

Wylie, Neil, Adib, Reza, Barbour, Andrew P., Fawcett, Jonathan, Hill, Alexander, Lynch, Stephen, Martin, Ian, O'Rourke, Thomas R., Puhalla, Harald, Rutherford, Leigh, Slater, Kellee, Whiteman, David C., Neale, Rachel E. and Queensland Pancreatic Cancer Study Group (2012). Surgical management in patients with pancreatic cancer: a Queensland perspective. ANZ Journal of Surgery, 83 (11), 859-864. doi: 10.1111/j.1445-2197.2012.06312.x

Clinical issues in oesophageal adenocarcinoma: could DNA copy number hold the key?

Frankel, Adam, Nancarrow, Derek, Wayte, Nicola and Barbour, Andrew (2012). Clinical issues in oesophageal adenocarcinoma: could DNA copy number hold the key?. Anz Journal of Surgery, 82 (9), 599-606. doi: 10.1111/j.1445-2197.2012.06144.x

Modeling the cost-effectiveness of strategies for treating esophageal adenocarcinoma and high-grade dysplasia

Gordon, Louisa G., Hirst, Nicholas G., Mayne, George C., Watson, David I., Bright, Timothy, Cai, Wang, Barbour, Andrew P., Smithers, Bernard M., Whiteman, David C. and Eckermann, Simon (2012). Modeling the cost-effectiveness of strategies for treating esophageal adenocarcinoma and high-grade dysplasia. Journal of Gastrointestinal Surgery, 16 (8), 1451-1461. doi: 10.1007/s11605-012-1911-9

An innovative approach for locally advanced stage III cutaneous melanoma: radiotherapy, followed by nodal dissection

Foote, Matthew, Burmeister, Bryan, Dwyer, Patrick, Burmeister, Elizabeth, Lambie, Duncan, Allan, Christopher, Barbour, Andrew, Bayley, Gerard, Pullar, Andrew, Meakin, Janelle, Thomas, Janine and Smithers, Mark (2012). An innovative approach for locally advanced stage III cutaneous melanoma: radiotherapy, followed by nodal dissection. Melanoma Research, 22 (3), 257-262. doi: 10.1097/CMR.0b013e3283531335

Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors

Andersen, Jesper B., Spee, Bart, Blechacz, Boris R., Avital, Itzhak, Komuta, Mina, Barbour, Andrew, Conner, Elizabeth A., Gillen, Matthew C., Roskams, Tania, Roberts, Lewis R., Factor, Valentina M. and Thorgeirsson, Snorri S. (2012). Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors. Gastroenterology, 142 (4), 1021-1031.e15. doi: 10.1053/j.gastro.2011.12.005

Management of loco-regionally recurrent melanoma

Geere, Simone L. and Barbour, Andrew P. (2012). Management of loco-regionally recurrent melanoma. Cancer Forum, 36 (3), 166-170.

Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis

Sjoquist, Katrin M., Burmeister, Bryan H., Smithers, B. Mark, Zalcberg, John R., Simes, R. John, Barbour, Andrew, Gebski, Val and for the Australasian Gastro-Intestinal Trials Group (2011). Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncology, 12 (7), 681-692. doi: 10.1016/S1470-2045(11)70142-5

Defining cure for esophageal cancer: Analysis of actual 5-year survivors following esophagectomy

Hirst, Jodi, Smithers, Bernard Mark, Gotley, David C., Thomas, Janine and Barbour, Andrew (2011). Defining cure for esophageal cancer: Analysis of actual 5-year survivors following esophagectomy. Annals of Surgical Oncology, 18 (6), 1766-1774. doi: 10.1245/s10434-010-1508-z

Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial

Burmeister, Bryan H., Thomas, Janine M., Burmeister, Elizabeth A., Walpole, Euan T., Harvey, Jennifer A., Thomson, Damien B., Barbour, Andrew P., Gotley, David C. and Smithers, B. Mark (2011). Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial. European Journal of Cancer, 47 (3), 354-360. doi: 10.1016/j.ejca.2010.09.009

Biomarkers in oesophagogastric cancers

Cameron, Andrew, Barbour, Andrew, Wayte, Nicci and Akhurst, Tim (2011). Biomarkers in oesophagogastric cancers. Cancer Forum, 35 (3), 160-166.

Risk stratification for early esophageal adenocarcinoma: Analysis of lymphatic spread

Barbour, Andrew P., Jones, Mark, Brown, Ian, Gotley, David C., Martin, Ian, Thomas, Janine, Clouston, Andre and Smithers, B. Mark (2010). Risk stratification for early esophageal adenocarcinoma: Analysis of lymphatic spread. Annals of Surgical Oncology, 17 (9), 2494-2502. doi: 10.1245/s10434-010-1025-0

Thoracoscopic-assisted esophagectomy for esophageal cancer: Analysis of patterns and prognostic factors for recurrence

Thomson, Iain G., Smithers, Bernard M., Gotley, David C., Martin, Ian, Thomas, Janine M., O'Rourke, Peter and Barbour, Andrew P. (2010). Thoracoscopic-assisted esophagectomy for esophageal cancer: Analysis of patterns and prognostic factors for recurrence. Annals of Surgery, 252 (2), 281-291. doi: 10.1097/SLA.0b013e3181e909a2

Isolated limb infusion for malignant melanoma: Predictors of response and outcome

Barbour, A. P., Thomas, J., Suffolk, J., Beller, E. and Smithers, B. M, (2009). Isolated limb infusion for malignant melanoma: Predictors of response and outcome. Annals of Surgical Oncology, 16 (12), 3463-3472. doi: 10.1245/s10434-009-0717-9

Prognostic value maximum standardized uptake value from preoperative positron emission tomography in resectable adenocarcinoma of the esophagus treated by surgery alone

Shenfine, J., Barbour, A. P., Wong, D., Martin, I., Gotley, D. C. and Smithers, B. M. (2009). Prognostic value maximum standardized uptake value from preoperative positron emission tomography in resectable adenocarcinoma of the esophagus treated by surgery alone. Diseases of the Esophagus, 22 (8), 668-675. doi: 10.1111/j.1442-2050.2009.00941.x

Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response

Barbour, A.P., Jones, M., Gonen, M., Gotley, D.C., Thomas, J., Thomson, D.B., Burmeister, B. and Smithers, B.M. (2008). Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response. Annals of Surgical Oncology, 15 (10), 2894-2902. doi: 10.1245/s10434-008-0084-y

Consideration of mesh-related complications: Letters and comments

Shenfine, Jon, Barbour, Andrew, Martin, Ian, Smithers, B. Mark and Gotley, David C. (2008). Consideration of mesh-related complications: Letters and comments. Annals of the Royal College of Surgeons of England, 90 (2), 175-176. doi: 10.1308/003588408X261780

Health-related quality of life among patients with adenocarcinoma of the gastro-oesophageal junction treated by gastrectomy or oesophagectomy

Barbour, A.P., Lagergren, P., Hughes, R., Alderson, D., Barham, C.P. and Blazeby, J.M. (2008). Health-related quality of life among patients with adenocarcinoma of the gastro-oesophageal junction treated by gastrectomy or oesophagectomy. British Journal of Surgery, 95 (1), 80-84. doi: 10.1002/bjs.5912

Endoscopic ultrasound predicts outcomes for patients with adenocarcinoma of the gastroesophageal junction

Barbour, Andrew P., Rizk, Nabil P., Gerdes, Hans, Bains, Manjit S., Rusch, Valerie W., Brennan, Murray F. and Coit, Daniel G. (2007). Endoscopic ultrasound predicts outcomes for patients with adenocarcinoma of the gastroesophageal junction. Journal of the American College of Surgeons, 205 (4), 593-601. doi: 10.1016/j.jamcollsurg.2007.05.010

Adenocarcinoma of the gastroesophageal junction: Influence of esophageal resection margin and operative approach on outcome

Barbour, Andrew P., Rizk, Nabil P., Gonen, Mithat, Tang, Laura, Bains, Manjit S., Rusch, Valerie W., Coit, Daniel G. and Brennan, Murray F. (2007). Adenocarcinoma of the gastroesophageal junction: Influence of esophageal resection margin and operative approach on outcome. Annals of Surgery, 246 (1), 1-8. doi: 10.1097/01.sla.0000255563.65157.d2

Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): Impact of adequate staging on outcome

Barbour, Andrew P., Rizk, Nabil P., Gonen, Mithat, Tang, Laura, Bains, Manjit S., Rusch, Valerie W., Coit, Daniel G. and Brennan, Murray F. (2007). Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): Impact of adequate staging on outcome. Annals of Surgical Oncology, 14 (2), 306-316. doi: 10.1245/s10434-006-9166-x

Outcomes from salvage esophagectomy post definitive chemoradiotherapy compared with resection following preoperative neoadjuvant chemoradiotherapy

Smithers, B. M., Cullinan, M., Thomas, J. M., Martin, I., Barbour, A. P., Burmeister, B. H., Harvey, J. A., Thomson, D. B., Walpole, E. T. and Gotley, D. C. (2007). Outcomes from salvage esophagectomy post definitive chemoradiotherapy compared with resection following preoperative neoadjuvant chemoradiotherapy. Diseases of The Esophagus, 20 (6), 471-477. doi: 10.1111/j.1442-2050.2007.00701.x

Current concepts of tumour metastasis

Barbour, A. and Gotley, D. C. (2003). Current concepts of tumour metastasis. Annals Academy of Medicine Singapore, 32 (2), 176-184.

Expression of the CD44v2-10 isoform confers a metastatic phenotype: Importance of the heparan sulfate attachment site CD44v3

Barbour, A. P., Reeder, J. A., Walsh, M. D., Fawcett, J., Antalis, T. M. and Gotley, D. C. (2003). Expression of the CD44v2-10 isoform confers a metastatic phenotype: Importance of the heparan sulfate attachment site CD44v3. Cancer Research, 63 (4), 887-892.

Neoadjuvant therapy for esophageal adenocarcinoma: a propensity score-matched comparison of paclitaxel and carboplatin chemoradiotherapy with cisplatin and 5-fluoruracil-based chemo- or chemoradiotherapy

Barbour, A. P., Brosda, S., Wijnhoven, B., van Hootgem, S., Lanschot, J. J. B., Barbour, S., Lagarde, S., Krause, L., Pryor, D., Thomas, J., Walpole, E. T., van der Gaast, A. and Smithers, M. (2018). Neoadjuvant therapy for esophageal adenocarcinoma: a propensity score-matched comparison of paclitaxel and carboplatin chemoradiotherapy with cisplatin and 5-fluoruracil-based chemo- or chemoradiotherapy. 43rd ESMO Congress (ESMO), Munich, Germany, 19-23 October 2018. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/annonc/mdy282.015

Long-term health-related quality of life following esophagectomy: A nonrandomized comparison of thoracoscopically assisted and open surgery

Barbour, Andrew P., McCormack, Orla M. , Baker, Peter J., Hirst, Jodi, Krause, Lutz, Brosda, Sandra, Thomas, Janine M., Blazeby, Jane M., Thomson, Iain G., Gotley, David C. and Smithers, Bernard M. (2017). Long-term health-related quality of life following esophagectomy: A nonrandomized comparison of thoracoscopically assisted and open surgery. Philadelphia, PA United States: Lippincott Williams & Wilkins. doi: 10.1097/SLA.0000000000001899

An AGITG trial - A randomised phase II study of pre-operative cisplatin, fluorouracil and DOCetaxel plus /-radio Therapy based on poOR early response to cisplatin and fluorouracil for resectable esophageal adenocarcinoma

Barbour, A., Walpole, E., Mai, G. T., Chan, H., Barnes, E., Watson, D., Ackland, S., Wills, V., Martin, J., Burge, M., Karapetis, C., Shannon, J., Nott, L., Gebski, V., Wilson, K., Thomas, J., Lampe, G., Zalcberg, J., Simes, J. and Smithers, M. (2016). An AGITG trial - A randomised phase II study of pre-operative cisplatin, fluorouracil and DOCetaxel plus /-radio Therapy based on poOR early response to cisplatin and fluorouracil for resectable esophageal adenocarcinoma. 41st Congress of the European-Society-for-Medical-Oncology (ESMO), Copenhagen, Denmark, 7-11 October 2016. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/annonc/mdw371.02

Prognostic value of nomograms incorporating biomarkers vs. sentinel node status in patients with stage IB and II melanoma

Rowe, C., Tang, F., Hughes, M. C., Rodero, M., Malt, M., Lambie, D., Barbour, A., Hayward, N., Smithers, B. M., Green, A. and Khosrotehrani, K. (2016). Prognostic value of nomograms incorporating biomarkers vs. sentinel node status in patients with stage IB and II melanoma. Australasian College of Dermatologists 49th Annual Scientific Meeting, Perth, Australia, 14–17 May, 2016. Richmond, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/ajd.12480

Discovery and validation of novel serum glycoprotein biomarkers for Barrett's esophagus and esophageal adenocarcinoma

Shah, Alok K., Chen, David, Le Cao, Kim-Anh, Choi, Eunju, Nancarrow, Derek, Whiteman, David, Saunders, Nicholas A., Barbour, Andrew P. and Hill, Michelle M. (2014). Discovery and validation of novel serum glycoprotein biomarkers for Barrett's esophagus and esophageal adenocarcinoma. 105th Annual Meeting of the American Association for Cancer Research (AACR), San Diego, CA United States, 05-09 April 2014. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1538-7445.AM2014-2492

Oesophageal adenocarcinoma genomics

Barbour, Andrew (2014). Oesophageal adenocarcinoma genomics. Sydney Cancer Conference, The University of Sydney, Australia, 26 November 2014. West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12282

DOCTOR: A randomized phase II trial of preoperative cisplatin, 5-fluorouracil, and docetaxel with or without radiotherapy based on poor early response to standard chemotherapy for resectable adenocarcinoma of the esophagus and/or OG junction

Barbour, Andrew, Smithers, Bernard Mark, Burmeister, Bryan, Zalcberg, John Raymond, Spry, Nigel, Smith, Garrett, Wilson, Kate, Roff, Kate, Yip, Sonia and Walpole, Euan Thomas (2012). DOCTOR: A randomized phase II trial of preoperative cisplatin, 5-fluorouracil, and docetaxel with or without radiotherapy based on poor early response to standard chemotherapy for resectable adenocarcinoma of the esophagus and/or OG junction. 48th Annual Meeting of the American Society of Clinical Oncology (ASCO), Chicago, Il United States, 01-06 June 2012. Alexandria, VA United States: American Society of Clinical Oncology.

Gene expression analysis of EAC in association with PET response.

Wayte, Nicola, Nancarrow, Derek, Walpole, Euan Thomas, Lampe, Guy, Gotley, David, Smithers, Bernard Mark and Barbour, Andrew (2012). Gene expression analysis of EAC in association with PET response.. ASCO GI Symposium, San Diego, California, 24 January 2012. Alexandria, VA, United States: American Society of Clinical Oncology. doi: 10.1200/jco.2012.30.4_suppl.50

Genomic and genetic characterization of human Cholangiocarcinoma identifies treatment options for tyrosine kinase inhibitors

Andersen, Jesper B., Spee, Bart, Blechacz, Boris, Avital, Itzhak, Komuta, Mina, Barbour, Andrew, Roskams, Tania, Roberts, Lewis R., Factor, Valentina M. and Thorgeirsson, Snorri S. (2011). Genomic and genetic characterization of human Cholangiocarcinoma identifies treatment options for tyrosine kinase inhibitors. 62nd Annual Meeting of the American Association for the Study of Liver Diseases, San Francisco, CA, United States, 04-08 November 2011.

A randomised phase II trial comparing pre-operative chemotherapy with pre-operative chemoradiation therapy for localized carcinoma of the oesophagus

Burmeister, B. H., Smithers, B. M., Thomas, J., Burmeister, E., Walpole, E., Harvey, J., Thomson, D., Barbour, A. and Gotley D. (2008). A randomised phase II trial comparing pre-operative chemotherapy with pre-operative chemoradiation therapy for localized carcinoma of the oesophagus. Clinical Oncological Society of Australia and the International Association of Cancer Registries Joint Scientific Meeting, held in conjunction with the Australian and New Zealand Gastro-Oesophageal Surgery Association, Sydney, Australia, 18-20 November 2008. United Kingdom: Wiley-Blackwell. doi: 10.1111/j.1743-7563.2008.00201_1.x

Minimally invasive esophagectomy for esophageal cancer: Analysis of recurrence patterns and prognostic factors of recurrence

Barbour, A., Thompson, I., Gotley, D. C., Jones, M., Thomas, J., Martin, I. and Smithers, M. B. (2008). Minimally invasive esophagectomy for esophageal cancer: Analysis of recurrence patterns and prognostic factors of recurrence. Clinical Oncological Society of Australia and the International Association of Cancer Registries Joint Scientific Meeting, held in conjunction with the Australian and New Zealand Gastro-Oesophageal Surgery Association, Sydney, Australia, 18–20 November 2008. United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/j.1743-7563.2008.00201_2.x

Surgery for early esophageal adenocarcinoma: Analysis of lymphatic spread and prognostic factors

Hughes, A., Smithers, B. M., Thomas, J., Martin, I., Gotley, D. C. and Barbour, A. P. (2007). Surgery for early esophageal adenocarcinoma: Analysis of lymphatic spread and prognostic factors. 60th Annual Cancer Symposium of the Society of Surgical Oncology, Washington, DC, USA, 15-18 Mar, 2007. Hagerstown, U.S.A.: Springer.

Isolated limb infusion (ILI) for malignant melanoma: Predictors of response and outcome

Barbour, A.P., Beller, E. and Smithers, B.M. (2006). Isolated limb infusion (ILI) for malignant melanoma: Predictors of response and outcome. The 59th Annual Cancer Symposium of the Society of Surgical Oncology, San Diego, CA, 23-26 March 2006. Hagerstown, U.S.A.: Springer.

Isolated limb infusion (ILT) for malignant melanoma: Predictors of response and outcome

Barbour, AP, Beller, E and Smithers, BM (2006). Isolated limb infusion (ILT) for malignant melanoma: Predictors of response and outcome. 59th Annual Cancer Symposium of the Society-of-Surgical-Oncology, San Diego CA, MAR 23-26, 2006. NEW YORK: SPRINGER.

Patterns and predictors of initial recurrence following resection for adenocarcinoma of the oesophagus and gastro-oesophageal junction

Barbour, A. P., Smithers, B. M., Gotley, D. C., Thomas, J., Burmeister, B. H. and Walpole, E. T. (2006). Patterns and predictors of initial recurrence following resection for adenocarcinoma of the oesophagus and gastro-oesophageal junction. The RACS Annual Scientific Congress, Sydney Convention & Exhibition Centre, Darling Harbour, Sydney, 15-19 May 2006. Australia: Blackwell Publishing Asia.

Refining oesophageal cancer staging after neoadjuvant therapy: importance of primary tumour response

Barbour, A. P., Smithers, B. M., Gotley, D. C., Thomas, J., Burmeister, B. H. and Thompson, D. (2006). Refining oesophageal cancer staging after neoadjuvant therapy: importance of primary tumour response. The RACS Annual Scientific Congress, Sydney Convention & Exhibition Centre, Darling Harbour, Sydney, 15-19 May, 2006. Australia: Blackwell Publishing Asia.

Glycosaminoglycan-modified CD44v3 confers a metastatic phenotype on a human hepatocellular carcinoma (HCC) cell line in a murine model

Barbour, A., Reeder, J., Fawcett, J., Walsh, M., Antalis, T. M. and Gotley, D. C. (2000). Glycosaminoglycan-modified CD44v3 confers a metastatic phenotype on a human hepatocellular carcinoma (HCC) cell line in a murine model. 91st Annual Meeting of American Association for Cancer Research, San Francisco, 1-5 Apr, 2000. Philadelphia, U.S.A.: American Association for Cancer Research.